FDA 483 - University of Kentucky - November 21, 2019

The University of Kentucky's non-clinical laboratory received a Form FDA 483 citing multiple significant deviations from Good Laboratory Practice (GLP) regulations. Observations included failures in data retention, archiving, protocol adherence, quality assurance documentation, and personnel qualifications. These issues indicate a systemic lack of control over critical aspects of nonclinical studies.